NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
Back to search
Official data from USPTO
VELAVIGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VELAVIGO
ST13
US500000090838630Class
5, 35, 42, 44
Filing
90838630
Registration
7238766
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/12/2023
Trademark type
Word
Nice classes
5, 35, 42, 44
Filing date
07/20/2021
Registration date
12/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
12/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
SHANGHAI, PILOT FREE TRADE ZONE, CN
Examiner
MCCLELLAN, MATTHEW
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VELAVIGO (SHANGHAI) LIMITED
L. J. (pessoa física)
Representatives
Kathryn E. Smith Wood Herron & Evans LLP
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for medical purposes used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; bulk drugs in the nature of pharmaceutical preparationsfor treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; diagnostic preparations for medical purposes; biochemical medicinesfor use in treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; diagnostic biomarker reagents for medical purposes; medicines for human purposes used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; pharmaceutical preparations used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; chemico-pharmaceutical preparations used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerautoimmune diseasesinflammation and antivirals; biological preparations for medical purposes used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasesautoimmune diseasesinflammationcancerantivirals; chemical preparations for pharmaceutical purposes used for treating tumorsophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasesautoimmune diseasesinflammationcancerantivirals; radioactive substances for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
Class 35
Publicity services; marketing servicespresentation of goods on communication mediafor retail purposes; business management assistance; marketing; personnel recruitment; compilation of information into computer databases; accounting; sponsorship search; rental of vending machines; rental of sales stands; retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; retail and wholesale store services for medicines; retail and wholesale store services for pharmaceutical preparations; retail and wholesale store services for sanitary preparations; retail and wholesale store services for medical supplies; retail and wholesale store services for veterinary medicines; retail and wholesale store services for veterinary preparations
Class 42
Scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; quality control for others; surveying; chemical analysis; research in the field of chemistry; chemical research; chemical research services; chemical research and analysis; cosmetic research; biochemical research and analysis; conducting early evaluation in the field of new pharmaceuticals; drug discovery services; pharmaceutical product evaluation; pharmaceutical research services; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; scientific research in the nature of conducting clinical trials for others; biotechnology research; biological research; biological research and analysis; biomedical research services; medical laboratory services; medical research; medical research services; meteorological information; material testing; industrial design; architectural services; dress designing; computer programming in the medical field; authenticating works of art; graphic arts design; cloud seeding; handwriting analysis; cartography services; rental of meters for the recording of energy consumption; business card design; graphic design of promotional materials
Class 44
Medical screening; genetic testing for medical purposes; medical analysis services for the diagnosis of cancer; medical services for the treatment of skin cancer; performing diagnosis of diseases; pharmaceutical advice; mental health therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; convalescent home services; food nutrition consultation; beauty salon services; animal breeding; plant nursery services; opticians' services; rental of sanitation facilities
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/05/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/11/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/09/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/26/2023
DOCK
ASSIGNED TO EXAMINER
11/23/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/24/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/24/2022
CNSL
SUSPENSION LETTER WRITTEN
10/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2022
GNRT
NON-FINAL ACTION E-MAILED
04/21/2022
CNRT
NON-FINAL ACTION WRITTEN
04/21/2022
DOCK
ASSIGNED TO EXAMINER
04/12/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/05/2021
ALIE
ASSIGNED TO LIE
10/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/21/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/17/2021
NWAP
NEW APPLICATION ENTERED
07/23/2021
Continuous trademark protection
Get notified about every new filing that threatens VELAVIGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.